These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11426017)

  • 21. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
    Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.
    Ikawa Y; Hamaguchi Y; Mugii N; Matsushita T; Takehara K
    Mod Rheumatol; 2017 Jul; 27(4):614-617. PubMed ID: 27830961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.
    D'Alto M; Riccardi A; Argiento P; Di Stefano I; Romeo E; Iacono AM; D'Andrea A; Fasano S; Sanduzzi A; Bocchino M; Docimo L; Tolone S; Russo MG; Valentini G
    Clin Exp Med; 2018 May; 18(2):237-243. PubMed ID: 28993902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.
    Zheng B; Vincent C; Fritzler MJ; Senécal JL; Koenig M; Joyal F
    J Rheumatol; 2017 Jan; 44(1):33-39. PubMed ID: 27744398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of systemic sclerosis in a district of northern Italy.
    Lo Monaco A; Bruschi M; La Corte R; Volpinari S; Trotta F
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S10-4. PubMed ID: 21586212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.
    Carreira PE; Carmona L; Joven BE; Loza E; Andréu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker U; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y
    Scand J Rheumatol; 2019 Jan; 48(1):42-51. PubMed ID: 30039730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Classification Criteria for Systemic Sclerosis (Scleroderma).
    Pope JE; Johnson SR
    Rheum Dis Clin North Am; 2015 Aug; 41(3):383-98. PubMed ID: 26210125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of skin involvement in systemic sclerosis.
    Kumánovics G; Péntek M; Bae S; Opris D; Khanna D; Furst DE; Czirják L
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v53-v66. PubMed ID: 28992173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic sclerosis in 2014: Advances in cohort enrichment shape future of trial design.
    Allanore Y; Distler O
    Nat Rev Rheumatol; 2015 Feb; 11(2):72-4. PubMed ID: 25561368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
    Pellar RE; Pope JE
    Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
    Reed J; Pope J
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
    Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
    Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.